Gilead Sciences, Inc.
GILD
Below: live stock price for Gilead Sciences, Inc. (GILD), a 1-year chart, 8 indicators (RSI, MACD, Bollinger, MA, EMA, Stochastic, ATR, Volume), and a compare mode. Add to your portfolio, star to your watchlist, or set a price alert in one place.
Gilead Sciences, Inc. (GILD) trades at 134.28 USD on investpig.
- Prev close
- $136.30
- Volume (24h)
- $926.97M
- Market cap
- $166.72B
- Currency
- USD
Score
50/ 100 · Mixed
- Value—
- Quality—
- Momentum—
- Growth—
- Risk—
- Dividend—
- Liquidity—
Composite of public market data. Informational only — not investment advice.
Trend projection
Where the recent trend points if it continues.
- +5 bars
- 134.0864 -0.14%
- +20 bars
- 133.8197 -0.34%
- +60 bars
- 133.7167 -0.42%
- +120 bars
- 133.713 -0.42%
Linear-regression continuation — not a prediction, not investment advice. ±1σ ≈ 68% range · ±2σ ≈ 95% range: ±0.0284 USD.
Interpretation
Price sits near the upper third of the recent range, trend is roughly flat.
Descriptive observation — not investment advice.
Reference levels
Fibonacci retracements and extensions across the recent range.
Reference only — not investment advice.
These coordinates describe past-trade clustering, not where to buy or sell. Do your own research before any trade.
- ResistanceFib +161.8% extension171.708 USD+27.87% from current
- ResistanceFib +100% extension159.83 USD+19.03% from current
- ResistanceFib +61.8% extension152.488 USD+13.56% from current
- ResistanceFib +27.2% extension145.8378 USD+8.61% from current
- ResistanceFib 23.6% retracement136.0741 USD+1.34% from current
- Current134.28 USD
- SupportFib 38.2% retracement133.268 USD-0.75% from current
- SupportFib 50% midpoint131 USD-2.44% from current
- SupportFib 61.8% retracement128.732 USD-4.13% from current
- SupportFib 78.6% retracement125.5031 USD-6.54% from current
- SupportFib −27.2% extension116.1622 USD-13.49% from current
- SupportFib −61.8% extension109.512 USD-18.45% from current
- SupportFib −100% extension102.17 USD-23.91% from current
Recent news
- What Comes After Merck’s Keytruda? The Race for the Next Standard Cancer Treatment.Barrons.com3h ago
- IHE vs. BBH: Which Healthcare ETF Is the Better Buy Right Now?Motley Fool22h ago
- Gilead Sciences (GILD) Sees a More Significant Dip Than Broader Market: Some Facts to KnowZacks2d ago
- IXJ vs. IBBQ: Global Healthcare vs. Biotech -- Which ETF Is the Better Buy?Motley Fool1d ago
- Neil Rimer thinks the AI money is coming back outTechCrunch2d ago
- Gilead Sciences, Inc. (GILD) is Attracting Investor Attention: Here is What You Should KnowZacks3d ago
- Gilead Leads The Battle Vs. HIV. But Rivals Are On The Move.Investor's Business Daily2d ago
- The Tech Selloff Is Turning Into a RoutBarrons.com2d ago
Related
Other assets in this category.
- 8306.TMitsubishi UFJ Financial Group, Inc.3,473 USD-4.30%
- 7203.TToyota Motor Corporation2,899.5 USD-0.33%
- 9984.TSoftBank Group Corp.5,424 USD-9.01%
- 6758.TSony Group Corporation3,470 USD+0.93%
- 6861.TKeyence Corporation70,880 USD-4.28%
- NVDANVIDIA Corporation202.81 USD-2.21%
- AAPLApple Inc.333.74 USD+0.14%
- 0700.HKTencent Holdings Limited477.8 USD+3.51%
Live discussion
Sign in to join the discussion.
- No comments yet. Be the first.